Samer al-Murrani

About Samer al-Murrani

Global academic & industrial human & animal health research & business experience spanning over 25 years- Strategic Business Consulting and Investor Outreach services, structuring life science based companies, assembling Board of Directors, executive coaching, intangible asset management and interim executive management services- Partnering with venture capital and private equity firms and Investment Banks on deal sourcing within the human and animal health field and providing human and animal health business valuation services and facilitating the due diligence process- Technology Commercialization and Business Development services- Innovative design of commercial product concepts for the human & pet health and food industries- Access to network CROs, CMOs and subject matter experts in a myriad or areas related to human and animal health and associated business and regulatory affairs- Market expansion services into the Middle East & helping international companies & investors establish operations or find channel partners within the United States- Extensive knowledge & experience with FDA (including CVM) regulatory requirements for medical device, human & veterinary health, drug & food product industries- Strong negotiation skills & extensive & mutually beneficial relationships with business partners & key opinion leaders in industry & academia worldwide- Extensive experience in advising marketing & advertising firms on the development of technical communication pieces- Inventor of US patents 7,700,280; 8,192,935 and 8,759,258; European patent 1,704,250 and Chinese Patent ZL on the discovery of molecular targets and diagnostic tests for ovarian and colon cancers and degenerative joint disease in cats- Numerous invited oral presentation & publications of science articles in peer-reviewed journals & a book chapter which appears in the 5th edition of Small Animal Clinical Nutrition.

Experience

1. Senior Advisor

   Wombat Capital

   Jan 2015 — Present · New York, FR

   Wombat Capital is an investment banking and strategic advisory firm with offices in New York and Paris. The firm has significant execution capabilities worldwide and serves a divers client base that includes companies, financial institutions, private equity firms and business owners. Wombat Capital\'s market acumen, global expertise, deal making skills and execution capabilities are instrumental in helping clients meet their financing needs, fulfill their strategic objectives and build corporate value.

Education

• Baker University

  M.B.A., Finance, General

  2005 — 2007

• The University of Edinburgh

  Ph.D., Immunology/Biochemistry

  1989 — 1994

• The University of Edinburgh

  B.Sc. (with honors), Animal Science

  1986 — 1989

Skills

• Life Science Investment Due Diligence
• Immunology
• Assay Development
• Genomics
• Life Science Consulting
• Molecular Diagnostics
• Biomarkers
• Microarray Analysis
• Animal Nutrition
• Operating Budgets
• Biotechnology
• Protein Purification
• Biomarker Discovery
• Microbiology
• Pharmaceutical Industry
• Fda
• Veterinary Medicine
• R&D
• Pharmacology
• Cell Culture
• Molecular Cloning
• Science
• Contract Negotiation
• Ingredients
• In Vitro
• Intangible Asset Management
• Drug Discovery
• Rnai
• Startup/Early Stage Company Valuations
• Biomarker Development
• Commercialization
• Cancer Research
• Team Management
• Nutrigenomics
• Metabolomics
• Genetics
• Proteomics
• Team Building
• Team Leadership
• Medical Devices